SCHEMBL4119081

SCHEMBL4119081

COc1ccc(CNc2ccc(C)cc2C(O)c2cccc(OC)c2C)c(OC)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
GAA P10253 3/20 0.45
TSHR P16473 10/20 0.44
MAPK1 P28482 4/20 0.44
ALDH1A1 P00352 4/20 0.44
POLB P06746 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
APLNR P35414 1/20 0.43
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
KDM4C Q9H3R0 1/20 0.42
NPC1 O15118 1/20 0.41
PKM P14618 1/20 0.41
RAB9A P51151 1/20 0.41
LMNA P02545 4/20 0.41
MAPT P10636 2/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4124049 0.91 TAS1R3 (0.44) TAS1R3TAS1R1GAATSHRMAPK1
SCHEMBL4119420 0.91 TSHR (0.51) TAS1R3TAS1R1GAATSHRMAPK1
SCHEMBL4122733 0.90 TAS1R3 (0.44) TAS1R3TAS1R1GAATSHRMAPK1
SCHEMBL4116863 0.90 TAS1R3 (0.44) TAS1R3TAS1R1GAATSHRMAPK1
SCHEMBL4114269 0.90 TAS1R3 (0.44) TAS1R3TAS1R1GAATSHRMAPK1
SCHEMBL4118899 0.87 TAS1R3 (0.42) TAS1R3TAS1R1GAATSHRMAPK1
SCHEMBL4120083 0.83 TSHR (0.43) TAS1R3TAS1R1GAATSHRMAPK1
SCHEMBL4117312 0.81 MAPT (0.42) TAS1R3TAS1R1GAATSHRMAPK1
SCHEMBL4119617 0.81 TAS1R3 (0.49) TAS1R3TAS1R1GAATSHRMAPK1
SCHEMBL4127432 0.80 APLNR (0.42) TAS1R3TAS1R1GAATSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR TAS1R3 3354/4885TAS1R1 2624/4885GAA 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.